While the advisory will tell recipients to watch out for certain symptoms for at least 28 days after taking the shot, experts say blood clo...

The findings are based on 280,000 people aged 18-65 who received a first dose of the Oxford-AstraZeneca vaccine.

The European Medicines Agency (EMA) was presenting its findings after the European Commission asked it to look into concerns that prompted ...

The agency said there were "no or limited data to change current recommendations." It said it wasn't known whether the risk of a rare blood...

Earlier this month, the Amsterdam-based drug regulator for the 27-nation European Union said there was a "possible link" between the AstraZ...

Nearly a million people have been given the first dose of the Indian-made vaccine in the country. No announcement of any halt to the vaccin...

The European Medicines Agency (EMA) said in a statement that it had found a "possible link" between the jab and the clots, following eight ...

AstraZeneca, which had been buffeted by similar blood-clotting concerns for weeks, agreed, while Pfizer Inc and Moderna executive declined,...

The pressure is on for governments that want to hasten immunizing millions of people over the next few months to understand the risk and av...

Concerning symptoms may occur a week to three weeks after the J&J vaccine.

With both the AstraZeneca and Johnson & Johnson (J&J)vaccines, the reports involve extremely rare clotting, including a type of blood clot ...

In a joint statement Tuesday, the Centers for Disease Control and Prevention and the Food and Drug Administration said they were investigat...

The EMA said its vaccine side effects monitoring system, as of April 4, had received 169 reports of cases of cerebral venous sinus thrombos...

MHRA, European Medicines Agency and the World Health Organization have reiterated that benefits of the vaccine in the prevention of COVID-1...

Australia launched mass vaccinations for its 25 million people in February, with most expected to receive the University of Oxford/AstraZen...

Earlier in March, more than a dozen countries, including Germany, suspended their use of AstraZeneca over the blood clot issue.

A growing number of European countries - including Germany, France, Italy and Spain - suspended use of the AstraZeneca vaccine on Monday, t...